Working… Menu
Trial record 4 of 5 for:    pu-ad

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04311515
Recruitment Status : Active, not recruiting
First Posted : March 17, 2020
Last Update Posted : October 12, 2020
Information provided by (Responsible Party):
Samus Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 23, 2022
Estimated Study Completion Date : December 31, 2022